{
  "cui": "C0008493",
  "cui_name": "Hydatidiform Mole, Invasive",
  "incidence_per_100k": 0.3,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 24000,
  "confidence": 0.5,
  "is_subtype": true,
  "parent_disease": "Gestational trophoblastic disease",
  "reasoning": "Occurs when molar tissue invades the myometrium, developing in approximately 15-20% of complete molar pregnancies. Estimated at ~0.3 per 100k person-years. Requires chemotherapy in most cases.",
  "data_quality": "moderate",
  "geographic_variation": "moderate",
  "year_specific": false,
  "data_year": null,
  "source": "Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",
  "source_url": "https://pubmed.ncbi.nlm.nih.gov/20728069/",
  "source_type": "literature"
}
